InsiderClue
Insiders · Profile

Seth Alpna

Director at Keros Therapeutics · Director at Bio-Techne. Filing since 9 Nov 2020. CIK 0001721020

KROS Keros Therapeutics, Inc. Director · 1 trade TECH Bio-Techne Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
KROS Keros Therapeutics, Inc.
4 Jun 2026
Director
Sold on a plan
2,625
$28.14K
21.2%
TECH Bio-Techne
9 Nov 2020
Director
Sold, plan not stated
5,023
$1.54M
70.1%
2 decisions on file.